The U.S. Centers for Medicare & Medicaid Services said on Wednesday it has extended key application deadlines for drugmakers ...
SHANGHAI, SHANGHAI, CHINA, April 30, 2026 /EINPresswire.com/ -- In today’s life sciences industry, moving a drug ...
The U.S. Centers for Medicare & Medicaid Services has extended application and participation deadlines for drugmakers and states to join its new Medicaid drug pricing model. The program, announced in ...
Insilico Medicine, a clinical-stage biotechnology company powered by generative artificial intelligence (AI), today announced ...
U.S. academic medical centers risk losing leadership in drug discovery and development as global competition—especially from ...
The U.S. Centers for Medicare & Medicaid Services has extended application deadlines for its Medicaid drug pricing model, giving drugmakers and states more time to participate in the effort to align ...
Lantern Pharma Inc. (NASDAQ: LTRN), a clinical-stage biotechnology company advancing precision oncology through its ...
It’s teaming up with Humana to challenge the system behind rising prescription costs.
Drug Target Review has launched an updated website to improve access to content across early-stage drug discovery, alongside ...
Researchers at McMaster University have developed a new generative artificial intelligence (AI) model capable of drastically speeding up drug discovery—and, in early tests, it has already designed a ...
President Donald Trump has struck a deal with the UK that exempts prescription drugs imported to the United States from ...
Bristol-Myers beats Q1 estimates as strong Growth Portfolio sales and Eliquis demand offset legacy drug declines.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results